Taft Indianapolis partner Neal Roach will moderate a panel discussion on "Five Things Going Forward," part of an Indiana University Kelley School of Business Center for the Business of Life Sciences conference presented virtually on April 30, 2021.
The "Lessons Learned from the Pandemic" conference will focus on how responses to the COVID-19 pandemic have driven significant innovations in areas ranging from vaccine development and drug repurposing to diagnostic and antibody testing, telemedicine and contact tracing. The pandemic has also prompted a relook at things like global supply chains, PPE strategic reserves, and just in time inventories. Speakers and panelists will discuss preparations for future pandemics, as well as the effects on current healthcare.
The "Five Things Going Forward" panel will feature Chris Otto, Senior Director, Clinical Laboratory Sciences, Eli Lilly and Company; Erica Anderson, Population Health Strategy Lead, Office of Population Health, Humana; Denis Johnson, Vice President and General Manager, Bloomington, Catalent Biologics; Chris Kiple, Former CEO, Ventec Life Systems; and Rusty Ring, Vice President Government Affairs, Roche Diagnostics.
Taft is also a sponsor of this event. For more information, or to register, click here.
Roach focuses his practice on transactional matters for companies for whom technology is critical, with a focus on intellectual property licensing. He has represented numerous startup and high-growth companies on a broad range of matters, including advice on intellectual property protection, management and licensing; contracts; FDA and other regulatory issues; corporate structure and governance; sales and marketing regulation; healthcare compliance; reimbursement; strategic partnership relationships.